• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三阴性乳腺癌中的铁死亡:与肿瘤浸润免疫细胞的相互作用及治疗意义

Ferroptosis in TNBC: interplay with tumor-infiltrating immune cells and therapeutic implications.

作者信息

Hu Lihong, Hu Jiejie, Qin Chengdong, Liu Siyuan, Yu Yang

机构信息

Postgraduate Training Base Alliance of Wenzhou Medical University, Zhejiang Cancer Hospital), Hangzhou, Zhejiang, China.

Department of Breast Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.

出版信息

Mol Cell Biochem. 2025 May 29. doi: 10.1007/s11010-025-05305-z.

DOI:10.1007/s11010-025-05305-z
PMID:40439838
Abstract

Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer with limited treatment options and a poor prognosis. Immunotherapy has emerged as a promising approach for TNBC, with tumor-infiltrating immune cells (TICs) in the tumor microenvironment (TME) serving as a critical cellular basis for its efficacy. However, the success of immunotherapy in TNBC is often limited due to the immunosuppressive nature of the TME and the heterogeneity of TNBC. Ferroptosis, a form of iron-dependent programmed cell death regulated by metabolic networks including iron, glutathione (GSH), and lipid metabolism, has shown potential to enhance anti-tumor immunity. Recent studies have demonstrated that ferroptosis can modulate immune responses by promoting the infiltration and activation of TICs, thereby improving the outcomes of immunotherapy. However, ferroptosis in immunosuppressive cells such as regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs) can trigger an "immunosuppressive wave," affecting other immune cells in the tumor immune microenvironment. This demonstrates the dual role of ferroptosis in TNBC therapy, emphasizing the need for a nuanced understanding of its effects on different immune cells and tumor cells. Herein, we further elaborate the role of ferroptosis in TNBC cells and its interactions with tumor-infiltrating immune cells (TICs) within the TME.

摘要

三阴性乳腺癌(TNBC)是一种侵袭性乳腺癌亚型,治疗选择有限且预后较差。免疫疗法已成为TNBC一种有前景的治疗方法,肿瘤微环境(TME)中的肿瘤浸润免疫细胞(TICs)是其疗效的关键细胞基础。然而,由于TME的免疫抑制性质和TNBC的异质性,免疫疗法在TNBC中的成功往往受到限制。铁死亡是一种由包括铁、谷胱甘肽(GSH)和脂质代谢在内的代谢网络调节的铁依赖性程序性细胞死亡形式,已显示出增强抗肿瘤免疫力的潜力。最近的研究表明,铁死亡可通过促进TICs的浸润和激活来调节免疫反应,从而改善免疫治疗的效果。然而,调节性T细胞(Tregs)和髓源性抑制细胞(MDSCs)等免疫抑制细胞中的铁死亡可引发“免疫抑制波”,影响肿瘤免疫微环境中的其他免疫细胞。这证明了铁死亡在TNBC治疗中的双重作用,强调需要细致了解其对不同免疫细胞和肿瘤细胞的影响。在此,我们进一步阐述铁死亡在TNBC细胞中的作用及其与TME内肿瘤浸润免疫细胞(TICs)的相互作用。

相似文献

1
Ferroptosis in TNBC: interplay with tumor-infiltrating immune cells and therapeutic implications.三阴性乳腺癌中的铁死亡:与肿瘤浸润免疫细胞的相互作用及治疗意义
Mol Cell Biochem. 2025 May 29. doi: 10.1007/s11010-025-05305-z.
2
Arsenene-Vanadene nanodots co-activate Apoptosis/Ferroptosis for enhanced chemo-immunotherapy.砷烯-钒烯纳米点共同激活凋亡/铁死亡以增强化学免疫疗法。
Acta Biomater. 2025 Apr;196:453-470. doi: 10.1016/j.actbio.2025.02.059. Epub 2025 Mar 1.
3
Iron-Dependent Cell Death: Exploring Ferroptosis as a Unique Target in Triple-Negative Breast Cancer Management.铁依赖性细胞死亡:探索铁死亡作为三阴性乳腺癌治疗的独特靶点
Cancer Manag Res. 2025 Mar 19;17:625-637. doi: 10.2147/CMAR.S503932. eCollection 2025.
4
Tumor-derived interleukin-34 creates an immunosuppressive and chemoresistant tumor microenvironment by modulating myeloid-derived suppressor cells in triple-negative breast cancer.肿瘤来源的白细胞介素-34 通过调节三阴性乳腺癌中的髓源抑制性细胞来创建免疫抑制和化疗耐药的肿瘤微环境。
Cancer Immunol Immunother. 2023 Apr;72(4):851-864. doi: 10.1007/s00262-022-03293-3. Epub 2022 Sep 14.
5
Tumor microenvironment and immunotherapy for triple-negative breast cancer.三阴性乳腺癌的肿瘤微环境与免疫治疗
Biomark Res. 2024 Dec 31;12(1):166. doi: 10.1186/s40364-024-00714-6.
6
Inhibition of cannabinoid receptor type 1 sensitizes triple-negative breast cancer cells to ferroptosis via regulating fatty acid metabolism.抑制大麻素受体 1 型通过调节脂肪酸代谢使三阴性乳腺癌细胞对铁死亡敏感。
Cell Death Dis. 2022 Sep 21;13(9):808. doi: 10.1038/s41419-022-05242-5.
7
Ferroptosis as a promising targeted therapy for triple negative breast cancer.铁死亡作为一种有前途的三阴性乳腺癌靶向治疗策略。
Breast Cancer Res Treat. 2024 Oct;207(3):497-513. doi: 10.1007/s10549-024-07387-7. Epub 2024 Jun 14.
8
Programmed cell death-related prognostic genes mediate dysregulation of the immune microenvironment in triple-negative breast cancer.程序性细胞死亡相关预后基因介导三阴性乳腺癌免疫微环境的失调。
Front Immunol. 2025 Mar 12;16:1563630. doi: 10.3389/fimmu.2025.1563630. eCollection 2025.
9
The role of ferroptosis in breast cancer: Tumor progression, immune microenvironment interactions and therapeutic interventions.铁死亡在乳腺癌中的作用:肿瘤进展、免疫微环境相互作用及治疗干预
Eur J Pharmacol. 2025 Jun 5;996:177561. doi: 10.1016/j.ejphar.2025.177561. Epub 2025 Mar 26.
10
Ferroptosis: a promising target for cancer immunotherapy.铁死亡:癌症免疫治疗的一个有前景的靶点。
Am J Cancer Res. 2021 Dec 15;11(12):5856-5863. eCollection 2021.

本文引用的文献

1
A positive-feedback loop suppresses TNBC tumour growth by remodeling tumour immune microenvironment and inducing ferroptosis.一个正反馈环通过重塑肿瘤免疫微环境和诱导铁死亡来抑制三阴性乳腺癌肿瘤生长。
Biomaterials. 2025 Apr;315:122960. doi: 10.1016/j.biomaterials.2024.122960. Epub 2024 Nov 12.
2
Neoadjuvant pembrolizumab plus chemotherapy/adjuvant pembrolizumab for early-stage triple-negative breast cancer: quality-of-life results from the randomized KEYNOTE-522 study.新辅助帕博利珠单抗联合化疗/辅助帕博利珠单抗治疗早期三阴性乳腺癌:来自随机 KEYNOTE-522 研究的生活质量结果。
J Natl Cancer Inst. 2024 Oct 1;116(10):1654-1663. doi: 10.1093/jnci/djae129.
3
Boswellia carterii n-hexane extract suppresses breast cancer growth via induction of ferroptosis by downregulated GPX4 and upregulated transferrin.
乳香树正己烷提取物通过下调 GPX4 和上调转铁蛋白诱导铁死亡来抑制乳腺癌生长。
Sci Rep. 2024 Jun 21;14(1):14307. doi: 10.1038/s41598-024-65170-6.
4
SBFI26 induces triple-negative breast cancer cells ferroptosis via lipid peroxidation.SBFI26 通过脂质过氧化诱导三阴性乳腺癌细胞发生铁死亡。
J Cell Mol Med. 2024 Apr;28(7):e18212. doi: 10.1111/jcmm.18212.
5
Cystine deprivation triggers CD36-mediated ferroptosis and dysfunction of tumor infiltrating CD8 T cells.胱氨酸缺乏会触发 CD36 介导的铁死亡和肿瘤浸润 CD8 T 细胞功能障碍。
Cell Death Dis. 2024 Feb 15;15(2):145. doi: 10.1038/s41419-024-06503-1.
6
Tetrahydrobiopterin inhibitor-based antioxidant metabolic strategy for enhanced cancer ferroptosis-immunotherapy.基于四氢生物蝶呤抑制剂的抗氧化代谢策略增强癌症铁死亡免疫治疗
J Colloid Interface Sci. 2024 Mar 15;658:100-113. doi: 10.1016/j.jcis.2023.12.042. Epub 2023 Dec 11.
7
Gankyrin inhibits ferroptosis through the p53/SLC7A11/GPX4 axis in triple-negative breast cancer cells.Gankyrin 通过 p53/SLC7A11/GPX4 轴抑制三阴性乳腺癌细胞中的铁死亡。
Sci Rep. 2023 Dec 8;13(1):21916. doi: 10.1038/s41598-023-49136-8.
8
Cancer-associated fibroblasts impair the cytotoxic function of NK cells in gastric cancer by inducing ferroptosis via iron regulation.肿瘤相关成纤维细胞通过铁调控诱导铁死亡从而抑制 NK 细胞的细胞毒性功能,进而影响胃癌的发生发展。
Redox Biol. 2023 Nov;67:102923. doi: 10.1016/j.redox.2023.102923. Epub 2023 Oct 6.
9
Neutrophils resist ferroptosis and promote breast cancer metastasis through aconitate decarboxylase 1.中性粒细胞通过 aconitate decarboxylase 1 抵抗铁死亡并促进乳腺癌转移。
Cell Metab. 2023 Oct 3;35(10):1688-1703.e10. doi: 10.1016/j.cmet.2023.09.004.
10
Comprehensive Analysis of SLC35A2 in Pan-Cancer and Validation of Its Role in Breast Cancer.泛癌中SLC35A2的综合分析及其在乳腺癌中作用的验证
J Inflamm Res. 2023 Aug 11;16:3381-3398. doi: 10.2147/JIR.S419994. eCollection 2023.